Two early recipients of CAR T-cell therapy — who had chronic lymphocytic leukemia at the time of treatment — remain cancer-free a decade later, researchers from the University of Pennsylvania in Philadelphia reported Feb. 2.
Read the full post on Becker's Hospital Review - Healthcare News
